Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24195000)

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

An approach to using recombinant erythropoietin for neuroprotection in very preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

The Effect of Recombinant Human Erythropoietin on Circulating Hematopoietic Progenitor Cells in Anemic Premature Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Recombinant erythropoietin and blood transfusion in selected preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Erythropoietin concentrations and neurodevelopmental outcome in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

How to administrate erythropoietin, intravenous or subcutaneous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Comparison between one and three doses a week of recombinant erythropoietin in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Red blood cell transfusion of preterm neonates with a Grade 1 intraventricular hemorrhage is associated with extension to a Grade 3 or 4 hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Development and characterization of novel erythropoiesis stimulating protein (NESP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Erythropoietin in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Do transfusions cause necrotizing enterocolitis? The complementary role of randomized trials and observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Erythropoietin as a retinal angiogenic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

The use of erythropoietin in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Why study erythropoietin in preterm infants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Current issues in neonatal transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Changing patterns of red blood cell transfusion in very low birth weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Erythropoietin for term and late preterm infants with hypoxic ischemic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

Preventive effect of different dosage of recombinant human erythropoietin on anemia of premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Blood transfusion. Iron load and retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Prediction of the need for transfusion during anemia of prematurity

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Postnatal changes in erythropoietin levels in untransfused premature infants

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Anemia of prematurity. Current concepts in the issue of when to transfuse.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Single-dose darbepoetin administration to anemic preterm neonates

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Effect of recombinant human erythropoietin on transfusion needs in preterm infants

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

The effect of recombinant human erythropoietin on the development of retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Effect of recombinant human erythropoietin in preterm infants

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Anemia of prematurity

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Use of erythropoietin and its effects on blood lactate and 2, 3-diphosphoglycerate in premature neonates

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Erythropoietin therapy for premature infants: cost without benefit?

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

Effect of short-term recombinant human erythropoietin therapy in the prevention of anemia of prematurity in very low birth weight neonates.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004863.PUB4

7 January 2021

10.1002/14651858.CD004863.PUB4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24771408

1 reference

Consolidated OpenCitations Corpus – April 2017